
Tagg M 1mg/500mg Tablet SR
Marketer
Events Pharma
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Tagg M 1mg/500mg Tablet SR
Diabetic patients diagnosed with type 2 diabetes mellitus may benefit from using Tagg M 1mg/500mg SR tablets, an anti-diabetic medication. This dual-action formulation manages blood glucose levels in adults. Administer Tagg M with food, consistently at the same time daily for optimal effectiveness. Dosage is determined individually by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to complications like nephropathy, retinopathy, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect; be aware of symptoms (sweating, dizziness, headache, tremors) and carry readily-available glucose sources (sugary foods or juice). Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain may also occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function) are recommended.
Uses of Tagg M 1mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Tagg M 1mg/500mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. The Tagg M 1mg/500mg sustained-release tablet should be taken with a meal.
Common Side effects of Tagg M 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Tagg M 1mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Tagg M 1mg/500mg sustained-release tablet should be taken with a meal.
How Tagg M 1mg/500mg Tablet SR works:
Tagg M SR tablets (1mg/500mg) combine glimepiride, a sulfonylurea, and metformin, a biguanide, to manage blood sugar. Glimepiride stimulates pancreatic insulin release, thus reducing blood glucose. Metformin concurrently reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use and Tagg M 1mg/500mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Tagg M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the benefits against possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Sustained-release Tagg M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Tagg M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Tagg M 1mg/500mg SR tablets. Physician consultation is necessary. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Tagg M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician before use. For those with mild to moderate liver disease, initiation should be at a low dose; however, Tagg M 1mg/500mg Tablet SR is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Tagg M 1mg/500mg Tablet SR :
Should you forget to take a Tagg M 1mg/500mg Tablet SR, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Tagg M 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
